TR199900505T2 - - Google Patents
Info
- Publication number
- TR199900505T2 TR199900505T2 TR1999/00505T TR9900505T TR199900505T2 TR 199900505 T2 TR199900505 T2 TR 199900505T2 TR 1999/00505 T TR1999/00505 T TR 1999/00505T TR 9900505 T TR9900505 T TR 9900505T TR 199900505 T2 TR199900505 T2 TR 199900505T2
- Authority
- TR
- Turkey
- Prior art keywords
- prophylaxis
- formulation
- treatment
- controlled release
- certain disorders
- Prior art date
Links
- WEVYAHXRMPXWCK-UHFFFAOYSA-N methyl cyanide Natural products CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 abstract 2
- -1 acetonitrile compound Chemical class 0.000 abstract 1
- 238000013270 controlled release Methods 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Hospice & Palliative Care (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9619074.9A GB9619074D0 (en) | 1996-09-12 | 1996-09-12 | Composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR199900505T2 true TR199900505T2 (enExample) | 1999-06-21 |
Family
ID=10799833
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR1999/00505T TR199900505T2 (enExample) | 1996-09-12 | 1997-09-08 |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP0929301A2 (enExample) |
| JP (1) | JP2001500150A (enExample) |
| KR (1) | KR20000036039A (enExample) |
| CN (2) | CN1235544A (enExample) |
| AR (1) | AR008176A1 (enExample) |
| AU (1) | AU724086B2 (enExample) |
| BR (1) | BR9711734A (enExample) |
| CA (1) | CA2265661A1 (enExample) |
| CO (1) | CO5031291A1 (enExample) |
| CZ (1) | CZ83299A3 (enExample) |
| GB (1) | GB9619074D0 (enExample) |
| HU (1) | HUP9904401A3 (enExample) |
| ID (1) | ID19589A (enExample) |
| IL (1) | IL128781A0 (enExample) |
| MA (1) | MA24359A1 (enExample) |
| NO (1) | NO991194D0 (enExample) |
| NZ (1) | NZ334268A (enExample) |
| PE (1) | PE2499A1 (enExample) |
| PL (1) | PL332074A1 (enExample) |
| TR (1) | TR199900505T2 (enExample) |
| WO (1) | WO1998010762A2 (enExample) |
| ZA (1) | ZA978133B (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2775597B1 (fr) * | 1998-03-04 | 2001-04-20 | Gattefosse Ets Sa | Pellet administrable par voie orale apte a ameliorer la biodisponibilite de la substance active, procede de fabrication |
| CA2323177A1 (en) * | 1998-03-11 | 1999-09-16 | Susan Marie Milosovich | Composition |
| DE19918325A1 (de) * | 1999-04-22 | 2000-10-26 | Euro Celtique Sa | Verfahren zur Herstellung von Arzneiformen mit regulierter Wirkstofffreisetzung mittels Extrusion |
| FR2796840B1 (fr) * | 1999-07-26 | 2003-06-20 | Ethypharm Lab Prod Ethiques | Comprimes faiblement doses et procede de preparation |
| US6733781B2 (en) | 2000-12-06 | 2004-05-11 | Wyeth | Fast dissolving tablet |
| PE20040134A1 (es) | 2002-07-25 | 2004-03-06 | Pharmacia Corp | Forma de dosificacion de una vez al dia de pramipexol |
| JP4808612B2 (ja) * | 2003-04-25 | 2011-11-02 | 田辺三菱製薬株式会社 | アルキレンジオキシベンゼン誘導体を含む経口投与用組成物 |
| PL1628642T3 (pl) * | 2003-05-14 | 2007-01-31 | Aptalis Pharma Ltd | Kontrolowane uwalnianie lekarstwa z kompozycji odpornej in vivo na mechaniczny stres |
| US20050142191A1 (en) * | 2003-06-23 | 2005-06-30 | Neurochem (International) Limited | Pharmaceutical formulations of amyloid inhibiting compounds |
| JP2005272347A (ja) * | 2004-03-24 | 2005-10-06 | Ohara Yakuhin Kogyo Kk | 固形製剤の製造方法 |
| UA95993C2 (ru) * | 2004-08-13 | 2011-09-26 | Бёрингер Ингельхайм Интернациональ Гмбх | Композиция пеллеты пролонгированного высвобождения, которая содержит прамипексол или его фармацевтически приемлемую соль, способ ее изготовления и ее применение |
| UA86831C2 (uk) | 2004-08-13 | 2009-05-25 | Бьорінгер Інгельхайм Інтернаціональ Гмбх | Композиція таблетки пролонгованого вивільнення, яка містить праміпексол або його фармацевтично прийнятну сіль, спосіб її виготовлення та її застосування |
| EP1970056A1 (en) * | 2007-03-15 | 2008-09-17 | Polichem S.A. | Time-specific delayed/pulsatile release dosage forms |
| US9132096B1 (en) | 2014-09-12 | 2015-09-15 | Alkermes Pharma Ireland Limited | Abuse resistant pharmaceutical compositions |
| EP3955910A4 (en) * | 2019-04-19 | 2023-01-25 | Hoffman Technologies LLC. | DELAYED RELEASE FORMULATION |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG48315A1 (en) * | 1989-04-13 | 1998-04-17 | Beecham Group Plc | Novel compounds |
| GB9409718D0 (en) * | 1994-05-14 | 1994-07-06 | Smithkline Beecham Plc | Novel compounds |
| GB9421472D0 (en) * | 1994-10-25 | 1994-12-07 | Smithkline Beecham Plc | Novel methods |
| AR004178A1 (es) * | 1995-07-29 | 1998-11-04 | Smithkline Beecham Plc | Procedimiento para la formulacion de un farmaco, una composicion farmaceutica obtenible mediante este procedimiento y el uso de la misma. |
-
1996
- 1996-09-12 GB GBGB9619074.9A patent/GB9619074D0/en active Pending
-
1997
- 1997-09-08 WO PCT/GB1997/002418 patent/WO1998010762A2/en not_active Ceased
- 1997-09-08 EP EP97939064A patent/EP0929301A2/en not_active Withdrawn
- 1997-09-08 KR KR1019997002030A patent/KR20000036039A/ko not_active Ceased
- 1997-09-08 IL IL12878197A patent/IL128781A0/xx unknown
- 1997-09-08 HU HU9904401A patent/HUP9904401A3/hu unknown
- 1997-09-08 PL PL97332074A patent/PL332074A1/xx unknown
- 1997-09-08 NZ NZ334268A patent/NZ334268A/xx unknown
- 1997-09-08 JP JP10513352A patent/JP2001500150A/ja active Pending
- 1997-09-08 BR BR9711734A patent/BR9711734A/pt unknown
- 1997-09-08 AU AU41288/97A patent/AU724086B2/en not_active Ceased
- 1997-09-08 CZ CZ99832A patent/CZ83299A3/cs unknown
- 1997-09-08 CN CN97199411A patent/CN1235544A/zh active Pending
- 1997-09-08 CA CA002265661A patent/CA2265661A1/en not_active Abandoned
- 1997-09-08 TR TR1999/00505T patent/TR199900505T2/xx unknown
- 1997-09-09 CO CO97052280A patent/CO5031291A1/es unknown
- 1997-09-10 PE PE1997000805A patent/PE2499A1/es not_active Application Discontinuation
- 1997-09-10 MA MA24792A patent/MA24359A1/fr unknown
- 1997-09-10 ID IDP973137A patent/ID19589A/id unknown
- 1997-09-10 ZA ZA978133A patent/ZA978133B/xx unknown
- 1997-09-10 AR ARP970104130A patent/AR008176A1/es not_active Application Discontinuation
-
1999
- 1999-03-11 NO NO991194A patent/NO991194D0/no unknown
-
2003
- 2003-01-23 CN CN03102977A patent/CN1446535A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| HUP9904401A2 (hu) | 2000-06-28 |
| IL128781A0 (en) | 2000-01-31 |
| GB9619074D0 (en) | 1996-10-23 |
| CO5031291A1 (es) | 2001-04-27 |
| EP0929301A2 (en) | 1999-07-21 |
| CN1446535A (zh) | 2003-10-08 |
| PE2499A1 (es) | 1999-03-24 |
| CZ83299A3 (cs) | 1999-08-11 |
| WO1998010762A3 (en) | 1998-06-04 |
| MA24359A1 (fr) | 1998-07-01 |
| KR20000036039A (ko) | 2000-06-26 |
| AU4128897A (en) | 1998-04-02 |
| ID19589A (id) | 1998-07-23 |
| HUP9904401A3 (en) | 2001-03-28 |
| ZA978133B (en) | 1999-04-12 |
| NO991194L (no) | 1999-03-11 |
| PL332074A1 (en) | 1999-08-30 |
| NO991194D0 (no) | 1999-03-11 |
| AR008176A1 (es) | 1999-12-09 |
| BR9711734A (pt) | 1999-08-24 |
| CN1235544A (zh) | 1999-11-17 |
| AU724086B2 (en) | 2000-09-14 |
| JP2001500150A (ja) | 2001-01-09 |
| CA2265661A1 (en) | 1998-03-19 |
| NZ334268A (en) | 2000-10-27 |
| WO1998010762A2 (en) | 1998-03-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR199900505T2 (enExample) | ||
| NO964966L (no) | Lactobacillusstammer av human opprinnelse, blandinger samt anvendelse derav | |
| PT1075415E (pt) | Arranjo para o controlo dinamico do caimento e adornamento de uma embarcacao | |
| EE9700310A (et) | N-propargüül-1-aminoindaani R-enantiomeeri, selle soolade ja kompositsioonide kasutamine | |
| TR199501441A2 (tr) | Islevsel poliorganosiloksanlar ve bunlarin hazirlanmasina mahsus islemlerden bir tanesi. | |
| ZA200007641B (en) | Treatment of airborne allergens. | |
| CY2431B1 (en) | Novel phenanthridines substituted in the 6 position. | |
| PT755249E (pt) | Utilizacao de inibidores da reaccao de maillard para o tratamento de doenca com base em amiloidose | |
| DE69914357D1 (de) | Pyridin-4-yl oder pyrimidin-4-yl substituierte pyrazine | |
| AP2000001796A0 (en) | The use of inhibitors of the renin-angiotensin system for the treatment of hypoxia or impaired metabolic function | |
| IT1285770B1 (it) | Composti corticoidei | |
| IT1306560B1 (it) | Dispositivo di regolazione e limitazione della miscela percarburatore. | |
| NO991459D0 (no) | Anvendelse av 1-hydroksy-2-pyridoner til behandling av hudinfeksjoner | |
| CA2408541A1 (en) | Treating eczema and/or psoriasis | |
| BR0209883A (pt) | Uso de inibidores da proteasoma para o tratamento de distúrbios do olho seco | |
| ES2167678T3 (es) | Tratamiento y profilaxis de la pancreatitis. | |
| EP0681787A3 (en) | Use of an enzyme for the manufacture of an agent suitable for the treatment and / or prophylaxis of coccidiosis. | |
| ES2186807T3 (es) | Inhibidores de trombina. | |
| BG100248A (bg) | Инхибитори на скваленсинтетаза | |
| EP0938898A3 (en) | Treatment of pruritus | |
| ES2194104T3 (es) | Uso de selegilina para el tratamiento de la perdida de audicion en mamiferos. | |
| DK1133296T3 (da) | Ny terapeutisk anvendelse af nicergolin | |
| NO20005548D0 (no) | Mykobakterieinhibitorer | |
| TR200002939T2 (tr) | Paroksetin maleat | |
| ITMI912466A1 (it) | Uso di 1, 2 dipalmitoil-l-alfa-fosfatidil-n, n-dimetiletanolammina, in composizioni dermatologiche |